Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 8, Issue 6, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-03-07
DOI
10.1161/jaha.118.010976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status
- (2018) Liping Mou et al. Circulation-Arrhythmia and Electrophysiology
- Multi-ethnic genome-wide association study for atrial fibrillation
- (2018) Carolina Roselli et al. NATURE GENETICS
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Association between oxidative stress and atrial fibrillation
- (2017) Ayman Samman Tahhan et al. HEART RHYTHM
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation
- (2017) Ingrid E Christophersen et al. NATURE GENETICS
- Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation
- (2017) Karin Willeit et al. JAMA Cardiology
- Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
- (2017) Lu-Chen Weng et al. CIRCULATION
- Genetic Architecture of the Cardiovascular Risk Proteome
- (2017) Mark D. Benson et al. CIRCULATION
- Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular DiseaseClinical Perspective
- (2016) Debby Ngo et al. CIRCULATION
- Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip
- (2016) Lars Lind et al. HEART
- Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
- (2016) Peter Ganz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study
- (2016) M. A. H. Sonneveld et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study
- (2015) Kristian B. Filion et al. AMERICAN HEART JOURNAL
- Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
- (2015) M. A. H. Sonneveld et al. BLOOD
- Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults
- (2015) Ayman A. Hussein et al. HEART RHYTHM
- B-type natriuretic peptide for incident atrial fibrillation—The Heinz Nixdorf Recall Study
- (2015) Kaffer Kara et al. Journal of Cardiology
- Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment
- (2015) Larissa Fabritz et al. Nature Reviews Cardiology
- Targeting BMP signalling in cardiovascular disease and anaemia
- (2015) Nicholas W. Morrell et al. Nature Reviews Cardiology
- Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
- (2015) Yetrib Hathout et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation
- (2014) Moritz F. Sinner et al. CIRCULATION
- Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
- (2014) Jehu S. Mathew et al. CIRCULATION
- B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies
- (2014) Moritz F. Sinner et al. EUROPACE
- Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
- (2014) Alvaro Alonso et al. Journal of the American Heart Association
- Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation
- (2013) Michiel Rienstra et al. AMERICAN HEART JOURNAL
- N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity
- (2013) Kristen K Patton et al. HEART
- Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis
- (2013) Na Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis
- (2013) Rukshana C. Shroff et al. PLoS One
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium
- (2013) Alvaro Alonso et al. Journal of the American Heart Association
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007
- (2012) Jonathan P. Piccini et al.
- Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy
- (2012) Bo Sun et al. HYPERTENSION
- Inflammation in Atrial Fibrillation
- (2012) Yutao Guo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-analysis identifies six new susceptibility loci for atrial fibrillation
- (2012) Patrick T Ellinor et al. NATURE GENETICS
- GATES: A Rapid and Powerful Gene-Based Association Test Using Extended Simes Procedure
- (2011) Miao-Xin Li et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community
- (2010) Renate B. Schnabel et al. CIRCULATION
- Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway
- (2010) Alok S. Pachori et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation
- (2010) Veronika Bruno et al. THROMBOSIS AND HAEMOSTASIS
- Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation
- (2009) Renate B. Schnabel et al. AMERICAN JOURNAL OF CARDIOLOGY
- N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation
- (2009) Kristen K. Patton et al. CIRCULATION
- Angiopoietin‐2 levels as a biomarker of cardiovascular risk in patients with hypertension
- (2008) Jeetesh V. Patel et al. ANNALS OF MEDICINE
- Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease
- (2008) Clarence M. Findley et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation
- (2008) Takashi Uemura et al. THROMBOSIS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started